Atlas Trials

Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia

Clinical trial NCT04147533 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04147533
Sponsor
Masaryk University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia, Chronic PhaseWithdrawal;Drug
Start date
2020-06-16
Primary completion
2026-06-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.